Ameritas Investment Partners, Inc. - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 81 filers reported holding RELMADA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$4,353
-48.9%
1,9260.0%0.00%
Q4 2022$8,513
-88.0%
1,9260.0%0.00%
-100.0%
Q3 2022$71,000
+97.2%
1,9260.0%0.00%
+50.0%
Q2 2022$36,000
-30.8%
1,9260.0%0.00%0.0%
Q1 2022$52,000
+85.7%
1,926
+55.1%
0.00%
+100.0%
Q4 2021$28,000
-15.2%
1,2420.0%0.00%0.0%
Q3 2021$33,000
-17.5%
1,2420.0%0.00%0.0%
Q2 2021$40,000
-9.1%
1,2420.0%0.00%
-50.0%
Q1 2021$44,000
+10.0%
1,2420.0%0.00%0.0%
Q4 2020$40,000
-14.9%
1,2420.0%0.00%0.0%
Q3 2020$47,000
-16.1%
1,2420.0%0.00%
-33.3%
Q2 2020$56,0001,2420.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders